A new report published today shows that the UK is trailing behind the rest of Europe in the treatment of cancer | ABPI
British patients have worse survival rates after five years – the international benchmark for measuring the quality of cancer care – compared to the European average in nine out of ten cancers – only exceeding the EU average in melanoma.
Despite the increasing burden of cancer on society, the UK spends over 20 per cent less per person on cancer than the top five EU economies; 20 per cent less of its total health budget on cancer than the rest of the EU; and 10 per cent less of its GDP on healthcare than the rest of the EU.
On cancer survival:
- UK cancer survival rates lag behind the European average in 9 out of 10 cancers
- If the UK achieved the cancer survival rates of Germany, over 35,000 more people would be alive five years after diagnosis.
- The UK has the worst survival outcomes across Europe for ovarian cancer. The UK’s Ovarian cancer survival rate is 34.0% of patients surviving for five years or more. European average is 40.8%
- The UK has the second worst survival rates for lung cancer – 8 per cent of patients surviving more than five years (ahead only of Bulgaria – 7 per cent). European average is 12.62 per cent.
- The UK has the second worst survival rates for pancreatic cancer – 3 per cent of patients surviving more than five years (ahead only of Iceland – 2.56 per cent) European average is 5.84 per cent.
- If the UK had the mortality rates of France, more than 100,000 women’s deaths could be prevented over the next ten years.
View the full report here